LSE · —
BioPharma Credit PLC (BPCP.L) Stock
$71.84
-0.64%
LSE: BPCP.L
—
—
Valuation
Financials & Margins
Latest News
Update: Cardinal Infrastructure Q2 Revenue Rises; 2026 Revenue Guidance Boosted
MT Newswires · Aug 11, 2026
Citigroup Upgrades Evolent Health to Buy From Neutral, Adjusts PT to $6 From $6.75
MT Newswires · Aug 11, 2026
Citigroup Upgrades Everpure to Buy From Neutral, Adjusts PT to $118 From $90
MT Newswires · Aug 11, 2026
Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105
MT Newswires · Aug 11, 2026
BTIG Downgrades Sionna Therapeutics to Neutral From Buy
MT Newswires · Aug 11, 2026
Valuation & Return Ratios
Peer Comparison
About BioPharma Credit PLC
—
over the past 52 weeks the stock has ranged between $0.64 and $72.13, and currently trades at its 52-week high.